https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-therapeutics-tracker
If anyone is interested in Covid-19 treatment plays you can take a look at HGEN and RLFTF. I am in both. They've shown amazing early data and are currently in phase 2b/3 trials. Peer reviewed data, partnership announcements, interim trial results and up-listings are in the near future. FDA approvals, EUA's or denials most likely in Sep/Oct.
Vaccines aren't going to solve the problem. Most won't even take them. Remdesivir, Dexamethasone and plasma are not working when we still have 1,000 deaths per day. The need for effective treatment has never been more important. It is what will get us back to normal. From the research I've done these are the current front-runners.
CYDY is also popular but I'm leery of their management team and phase 2 results. Lilly, Regeneron and some of the other big boys are still early in their testing trials.
Obviously do your own DD. BioPharma stocks are the riskiest out there. They are like lottery tickets. NFA